logo-cropped

Published in Insurance
Published in Insurance

ATLANTA, GA--(Marketwired - Nov 7, 2013) - MissionIR today announces the online availability of its interview with CytRx Corp. (NASDAQ: CYTR) President and Chief Executive Officer Steven Kriegsman, as well as the company's Vice President of Business Development and Investor Relations David Haen. The full audio interview is available at: http://cytr.missionir.com/interview.html.

CytRx is a biopharmaceutical R&D company developing cancer drugs for several indications. The company's primary focus is on its proprietary delivery technology for potent oncology therapies.

JW Player Module

You must have the Adobe Flash Player installed to view this player.

latter-blum2

Share Bayoubuzz

Powered By JFBConnect